TrialBlood advances2018

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

Shernan G Holtan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.